Clinical Trial

GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The objectives of this study are to compare the efficacy of the dual trigger group vs the hCG trigger group on the live birth rate in women undergoing IVF and the efficacy of the agonist in LP group vs the placebo group on the live birth rate in women undergoing FET.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-08-21; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2020-03-23
Trial Details
NCT Number NCT04064840
Lead Sponsor The University of Hong Kong
Conditions Subfertility
Enrollment 784 participants
Start Date 2019-09-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-15